Wai Lam Ling, Ph.D.
VP Scientific Advisory,
Catalent
Dr. Ling brings with her more than 25 years of experience in R&D and Chemistry, Manufacturing and Controls (CMC) operations across biologics and gene therapies, working for companies including Rocket Pharmaceuticals, Merck & Co (MSD) and Schering-Plough Corporation. She has led the development and regulatory filings of more than 20 biologic therapies, and supported the commercialization of several biologic products, including the cancer treatment, Keytruda®. She holds a bachelor’s degree in biochemistry from the University of California, Los Angeles, and gained a doctorate in pharmacology from Rutgers University before completing her post-doctoral research fellowship at the Albert Einstein College of Medicine, New York.